Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort.
- DOI
- 10.1186/s13075-020-02165-4
- Published
- 2020 Apr 28
- Container
- Arthritis research & therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13075-020-02165-4,
title = {Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort.},
author = {Dierckx S and Sokolova T and Lauwerys BR and Avramovska A and de Bellefon LM and Toukap AN and Stoenoiu M and Houssiau FA and Durez P},
year = {2020},
journal = {Arthritis research \& therapy},
doi = {10.1186/s13075-020-02165-4},
url = {https://doi.org/10.1186/s13075-020-02165-4}
}RIS
TY - JOUR TI - Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort. AU - Dierckx S AU - Sokolova T AU - Lauwerys BR AU - Avramovska A AU - de Bellefon LM AU - Toukap AN AU - Stoenoiu M AU - Houssiau FA AU - Durez P PY - 2020 JO - Arthritis research & therapy DO - 10.1186/s13075-020-02165-4 UR - https://doi.org/10.1186/s13075-020-02165-4 ER -
APA
S, D., T, S., BR, L., A, A., LM, D. B., AN, T., M, S., FA, H., & P, D. (2020). Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort.. Arthritis research & therapy. https://doi.org/10.1186/s13075-020-02165-4
Source records
- pubmed · retrieved 2026-09-25T15:04:38.089Z